Coley Pharmaceutical Group Inc (COLY)

Ticker: COLY


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Karobath Manfred E Non-Executive Director
Transaction date
Sale
Price
272.52
Quantity 27,721 -6.0%
Value US$2,439,047
Krieg Arthur M SVP, R & D, Chief Scien. Off. Officer
Transaction date
Sale
Price
312.67
Quantity 69,981 +6.7%
Value US$1,174,017
THOMAS JAMES E Non-Executive Director
Transaction date
Purchase
Price
372.82
Quantity 99,083 -9.8%
Value US$2,644,362
THOMAS JAMES E Non-Executive Director
Transaction date
Purchase
Price
8.68
Quantity 100,000 +5.3%
Value US$868,000
Karobath Manfred E Non-Executive Director
Transaction date
Purchase
Price
8.98
Quantity 7,000 +4.5%
Value US$62,860
Karobath Manfred E Non-Executive Director
Transaction date
Purchase
Price
9.01
Quantity 5,000 +3.3%
Value US$45,050
Karobath Manfred E Non-Executive Director
Transaction date
Purchase
Price
9.00
Quantity 5,000 +3.4%
Value US$45,000
Karobath Manfred E Non-Executive Director
Transaction date
Purchase
Price
8.99
Quantity 5,000 +3.6%
Value US$44,950
Karobath Manfred E Non-Executive Director
Transaction date
Purchase
Price
9.22
Quantity 5,000 +3.7%
Value US$46,100
Krieg Arthur M SVP, R & D, Chief Scien. Off. Officer
Transaction date
Sale
Price
2.24
Quantity 18,122 -3.1%
Value US$40,593
Krieg Arthur M SVP, R & D, Chief Scien. Off. Officer
Transaction date
Sale
Price
1.89
Quantity 13,210 -2.2%
Value US$24,967
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2007-12-14 2007-12-06 S Sale Karobath Manfred E Non-Executive Director
27,721 -6.0%
272.52
US$2,439,047
27,721 -6.0% 272.52 US$2,439,047
2007-08-29 2007-08-29 S Sale Krieg Arthur M

SVP, R & D, Chief Scien. Off.

Officer
69,981 +6.7%
312.67
US$1,174,017
69,981 +6.7% 312.67 US$1,174,017
2007-05-14 2007-05-11 B Purchase THOMAS JAMES E Non-Executive Director
99,083 -9.8%
372.82
US$2,644,362
99,083 -9.8% 372.82 US$2,644,362
2007-05-14 2007-05-10 B Purchase THOMAS JAMES E Non-Executive Director
100,000 +5.3%
8.68
US$868,000
100,000 +5.3% 8.68 US$868,000
2007-05-09 2007-05-08 B Purchase Karobath Manfred E Non-Executive Director
7,000 +4.5%
8.98
US$62,860
7,000 +4.5% 8.98 US$62,860
2007-05-09 2007-05-08 B Purchase Karobath Manfred E Non-Executive Director
5,000 +3.3%
9.01
US$45,050
5,000 +3.3% 9.01 US$45,050
2007-05-09 2007-05-08 B Purchase Karobath Manfred E Non-Executive Director
5,000 +3.4%
9.00
US$45,000
5,000 +3.4% 9.00 US$45,000
2007-05-09 2007-05-08 B Purchase Karobath Manfred E Non-Executive Director
5,000 +3.6%
8.99
US$44,950
5,000 +3.6% 8.99 US$44,950
2007-05-09 2007-05-08 B Purchase Karobath Manfred E Non-Executive Director
5,000 +3.7%
9.22
US$46,100
5,000 +3.7% 9.22 US$46,100
2006-12-11 2006-12-07 S Sale Krieg Arthur M

SVP, R & D, Chief Scien. Off.

Officer
18,122 -3.1%
2.24
US$40,593
18,122 -3.1% 2.24 US$40,593
2006-10-16 2006-10-13 S Sale Krieg Arthur M

SVP, R & D, Chief Scien. Off.

Officer
13,210 -2.2%
1.89
US$24,967
13,210 -2.2% 1.89 US$24,967
Explore more

More insider trading research around Coley Pharmaceutical Group Inc